Cargando…

Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy

Detalles Bibliográficos
Autores principales:	Kawakubo, Kazumichi, Fernández-del Castillo, Carlos, Liss, Andrew Scott
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596553/ https://www.ncbi.nlm.nih.gov/pubmed/36114896 http://dx.doi.org/10.1007/s00535-022-01922-3

Ejemplares similares

Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy
por: Kawakubo, Kazumichi, et al.
Publicado: (2022)

Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma
por: Li, Yan, et al.
Publicado: (2022)

Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

Correction: Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
Publicado: (2018)

Correction to: Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
por: Frampton, James E.
Publicado: (2020)

Correction to: Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression
por: Pan, Zongfu, et al.
Publicado: (2020)

Author Correction: Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature
por: Korsukewitz, Catharina, et al.
Publicado: (2020)

Correction: New insights into epigenetic regulation of resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms and therapeutic opportunities
por: Dai, Mengyuan, et al.
Publicado: (2022)

Correction: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent
por: Thakar, Manjusha, et al.
Publicado: (2020)

Correction to: Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma
por: Weng, Wanqing, et al.
Publicado: (2020)

Correction: Immunohistochemical Typing of Adenocarcinomas of the Pancreatobiliary System Improves Diagnosis and Prognostic Stratification
por: Fernández Moro, Carlos, et al.
Publicado: (2017)

Correction: Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis
por: Arundhathi, Arivajiagane, et al.
Publicado: (2019)

Correction: Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma
por: Gruber, Elisabeth S., et al.
Publicado: (2020)

Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma
por: Gimotty, Phyllis A., et al.
Publicado: (2022)

Correction to: Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era
por: Coyle, Patricia K., et al.
Publicado: (2021)

Correction: Autoimmunity in Arabidopsis acd11 Is Mediated by Epigenetic Regulation of an Immune Receptor
por: Palma, Kristoffer, et al.
Publicado: (2010)

Correction to: Immunology of allergen immunotherapy
Publicado: (2023)

Publisher Correction: Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice
por: Cáceres, Marta, et al.
Publicado: (2021)

Correction to: Nanotechnology-augmented sonodynamic therapy and associated immune-mediated effects for the treatment of pancreatic ductal adenocarcinoma
por: Hadi, Marym Mohammad, et al.
Publicado: (2023)

Correction: Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma
Publicado: (2021)

Correction: Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer
Publicado: (2021)

Correction: Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
Publicado: (2023)

Correction to: Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma
por: Chen, Yan, et al.
Publicado: (2021)

Correction: Epigenetic Regulation of a Murine Retrotransposon by a Dual Histone Modification Mark
por: Brunmeir, Reinhard, et al.
Publicado: (2011)

Correction: A Global Model for Bankruptcy Prediction
por: Alaminos, David, et al.
Publicado: (2018)

Correction: Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
Publicado: (2015)

Correction: Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Correction to: Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal‑venous enhancement phase
por: Reinert, Christian Philipp, et al.
Publicado: (2021)

Correction to: Epigenetic signatures associated with imprinted paternally expressed genes in the Arabidopsis endosperm
por: Moreno-Romero, Jordi, et al.
Publicado: (2019)

Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
por: Schirmer, Uwe, et al.
Publicado: (2018)

Correction: The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis
por: Yang, Di, et al.
Publicado: (2022)

Correction to: Transposon dynamics and the epigenetic switch hypothesis
por: Linquist, Stefan, et al.
Publicado: (2022)

Correction to: Long-term survival after hepatectomy for metachronous liver metastasis of pancreatic ductal adenocarcinoma: a case report
por: Tsutsumi, Chikanori, et al.
Publicado: (2020)

Correction: Genome-Wide Associations between Genetic and Epigenetic Variation Influence mRNA Expression and Insulin Secretion in Human Pancreatic Islets
Publicado: (2014)

Epigenetic regulation and role of metastasis suppressor genes in pancreatic ductal adenocarcinoma
por: Mardin, Wolf Arif, et al.
Publicado: (2013)

Publisher Correction: Epigenetic landscape reveals MECOM as an endothelial lineage regulator
por: Lv, Jie, et al.
Publicado: (2023)

Correction to: Immunotherapy in prostate cancer: new horizon of hurdles and hopes
por: Tsaur, Igor, et al.
Publicado: (2021)

Correction: Two roads for oncolytic immunotherapy development
Publicado: (2021)

Correction: Gluco-Incretins Regulate Beta-Cell Glucose Competence by Epigenetic Silencing of Fxyd3 Expression
Publicado: (2014)

Correction: Production and therapeutic use of astaxanthin in the nanotechnology era
por: Abdelazim, Karim, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ovp5gp00m9enpme9arbd4mv9f8